Entourage Health Reports Fiscal Year 2023 Financial Results and Posts $54 Million in Total Revenues
TORONTO, April 30, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE: 4WE) ("Entourage" or the "Company"),...
Month: April 2024
ZeroFox Threat Intelligence and Attack Surface Experts to Present at 2024 RSA Conference
WASHINGTON, April 30, 2024 (GLOBE NEWSWIRE) -- ZeroFox (Nasdaq: ZFOX), a leading provider of external cybersecurity, is exhibiting and speaking...
Veritone and OPEXUS Team Up to Provide AI Solutions to National Canadian Bank
Veritone Redact Provides Redaction Capabilities for OPEXUS’ ATIPXpress® AI Assist Module, Improving Data Privacy Workflows While Helping to Comply with...
LENDINGTREE REPORTS FIRST QUARTER 2024 RESULTS
Insurance Segment Strength and Operating Leverage Drive Strong Results at Top or Above of Forecasted Range CHARLOTTE, N.C., April 30,...
BIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS
MINNEAPOLIS, April 30, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced the appointment of Dr. Judith Klimovsky to serve as...
Strayer University Names Dr. Antoinette ‘Toni’ Farmer-Thompson President
Contacts Elaine Kincel 202-557-4920 Media.relations@strategiced.com Strayer University, a higher learning institution for working adults, has announced Dr. Antoinette ‘Toni’ Farmer-Thompson...
SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Healthcare Conference
BOSTON and ROLLE, Switzerland, April 30, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS, a cloud-native software company and a leader in...
PB Financial Corporation Declares Second-Quarter, 2024 Dividend
ROCKY MOUNT, NC / ACCESSWIRE / April 30, 2024 / Ted E. Whitehurst, President and CEO of PB Financial Corporation...
Debiopharm & Repare Therapeutics Announce First Patient Dosed in Phase 1/1b Mythic Trial Evaluating the Synthetic Lethal Combination of WEE1 AND PKMYT1 Inhibition
Contacts Debiopharm Dawn Bonine Head of Communications dawn.bonine@debiopharm.com Tel: +41 (0)21 321 01 11 Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based biopharmaceutical...
PolyPid Announces Enrollment of 200th Patient in Ongoing SHIELD II Phase 3 Trial Evaluating D-PLEX₁₀₀ for the Prevention of Abdominal Colorectal Surgical Site Infections
Study Approximately Half Enrolled to the Planned Unblinded Interim AnalysisUnblinded Interim Analysis to be Conducted Once Approximately 400 Patients Complete...
ProMIS Neurosciences Publishes Study Highlighting Oligomer Selectivity and Benefit of Amyloid-Beta-Directed Antibodies
CAMBRIDGE, Massachusetts and TORONTO, Ontario, April 30, 2024 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a biotechnology company focused...
Playboy Enters into Multiple New China License Agreements
LOS ANGELES, April 30, 2024 (GLOBE NEWSWIRE) -- PLBY Group, Inc. (NASDAQ: PLBY) (“PLBY Group” or the “Company”), a leading...
Oatly Reports First Quarter 2024 Financial Results
MALMÖ, Sweden, April 30, 2024 (GLOBE NEWSWIRE) -- Oatly Group AB (Nasdaq: OTLY) (“Oatly” or the “Company”), the world’s original...
Origin Materials Partners with PackSys Global on World’s First PET Cap and Closure Manufacturing System
Origin’s manufacturing system is expected to produce the first commercial-scale PET caps and closures Origin’s sustainable PET caps and closures...
Origin Materials Partners with PackSys Global on World’s First PET Cap and Closure Manufacturing System
Origin’s manufacturing system is expected to produce the first commercial-scale PET caps and closures Origin’s sustainable PET caps and closures...
OKYO Pharma Announces Upcoming Presentation of OK-101 Phase 2 Data for Dry Eye Disease at the Dry Horizons Symposium, a Partner Meeting of the Association for Research in Vision and Ophthalmology (ARVO)
LONDON and NEW YORK, April 30, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing...
Hot Chili Secures Large Addition to its Costa Fuego Coastal Copper Hub in Chile
Domeyko Consolidation Signficantly Boosts Exploration Pipeline PERTH, Australia, April 30, 2024 /PRNewswire/ - Hot Chili Limited (ASX: HCH) (TSXV: HCH)...
LGI Homes Reports First Quarter 2024 Results
THE WOODLANDS, Texas, April 30, 2024 (GLOBE NEWSWIRE) -- LGI Homes, Inc. (NASDAQ: LGIH) today announced financial results for the...
Laser Photonics Unveils New Compact CleanTech CR-3030 Laser Cleaning System
Contacts Investor Relations Contact: laser@haydenir.com Contact: Karla Kizzort Laser Photonics Corporation kkizzort@laserphotonics.com Laser Photonics Corporation (LPC) (NASDAQ: LASE), a leading...
I-MAB Filed 2023 Annual Report on Form 20-F
ROCKVILLE, Md., April 30, 2024 /PRNewswire/ -- I-Mab (the "Company") (NASDAQ: IMAB), a U.S.-based, global biotech company, exclusively focused on the development...
Harmony Biosciences Acquires Epygenix Therapeutics, Inc., Adding Late-Stage Epilepsy Franchise to Growing Pipeline of Innovative CNS Assets
Lead Candidate, EPX-100, Holds Orphan Drug and Rare Pediatric Disease Designations EPX-100 in Pivotal Registrational Trial for Dravet Syndrome; Topline...
H&E Equipment Services, Inc. Reports First Quarter 2024 Results
Contacts Leslie S. Magee Chief Financial Officer 225-298-5261 lmagee@he-equipment.com Jeffrey L. Chastain Vice President of Investor Relations 225-952-2308 jchastain@he-equipment.com H&E...
First National Corporation Reports First Quarter Financial Results
STRASBURG, Va., April 30, 2024 (GLOBE NEWSWIRE) -- First National Corporation (the “Company” or “First National”) (NASDAQ: FXNC), the bank...
Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)
- Company anticipates 10-month review for potential approval in Q1 2025 -- Eton expects ET-400 and Alkindi Sprinkle® to achieve...
Enanta Pharmaceuticals Announces the Appointment of Matthew P. Kowalsky as Chief Legal Officer
Contacts Media and Investors Jennifer Viera jviera@enanta.com Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule...
DURECT Corporation Announces Late-Breaking Oral Presentation at the EASL Congress 2024 to Discuss AHFIRM Phase 2b Data in Alcohol-Associated Hepatitis
CUPERTINO, Calif., April 30, 2024 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX), a late-stage biopharmaceutical company pioneering the development of epigenetic...
ONO Enters into a Definitive Agreement to Acquire Deciphera Pharmaceuticals
OSAKA, Japan, April 30, 2024 /PRNewswire/ -- ONO Pharmaceutical, Co., Ltd., (TSE: 4528, Representative Director, Chairman of the Board and...
Cyclacel Pharmaceuticals Announces $8.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules
BERKELEY HEIGHTS, N.J., April 30, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"),...
Cyclacel Pharmaceuticals Announces $8.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules
BERKELEY HEIGHTS, N.J., April 30, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"),...
Capital Product Partners L.P. Announces First Quarter 2024 Financial Results
ATHENS, Greece, April 30, 2024 (GLOBE NEWSWIRE) -- Capital Product Partners L.P. (the “Partnership”, “CPLP” or “we” / “us”) (NASDAQ:...
CECO Environmental Reports First Quarter 2024 Results
Reports Record First Quarter Revenue and Gross Margins, Near Record BacklogReaffirms Full Year 2024 GuidanceDALLAS, April 30, 2024 (GLOBE NEWSWIRE)...
AEP Reports First-Quarter 2024 Earnings, Reaffirms Guidance
AMERICAN ELECTRIC POWER Preliminary, unaudited results First Quarter ended March 31 2024 2023 Variance Revenue ($ in billions): 5.0...
Atico Updates Mineral Reserves and Resources for the El Roble Mine in Colombia
VANCOUVER, British Columbia, April 30, 2024 (GLOBE NEWSWIRE) -- Atico Mining Corporation (the “Company” or “Atico”) (TSX.V: ATY | OTC:...
Flow Beverage Corp. Announces Annual General Meeting Results
Contacts Trent MacDonald, Chief Financial Officer 1-844-356-9426 investors@flowhydration.com Investors: Marc Charbin investors@flowhydration.com Media: Natasha Koifman nk@nkpr.net Flow Beverage Corp. (TSX:FLOW;...
Luckin Coffee Inc. Announces First Quarter 2024 Financial Results
First Quarter Net Revenues Increased 41.5% to RMB6,278.1 MillionAverage Monthly Transacting Customers Increased 103.2% Compared to the Same Period Last...
Solaris Announces Award of Option to Acquire Key Concessions Hosting Porphyry Copper and Epithermal Gold Potential Adjacent to Warintza
VANCOUVER, British Columbia, April 30, 2024 (GLOBE NEWSWIRE) -- Solaris Resources Inc. (TSX: SLS; NYSE: SLSR) (“Solaris” or the “Company”)...
INEO Presents Retail Media Technology at OAAA Media Conference
INEO Retail Media and partner 41:10 Media unveil the future of in-store retail media at largest Out-of-Home advertising industry event...
Waldencast Reports Fiscal Year 2023 Financial Results
2023 Net Revenue of $218.1 millionGroup Combined Comparable Revenue of $212.5 million, a 15.3% increase vs 2022Group Combined Adjusted EBITDA...
Piedmont Lithium Announces Q1’24 North American Lithium Production Results
Piedmont shipped approximately 15,500 dmt of spodumene concentrate in Q1’24 Record quarterly production of 40,439 dmt achieved at NAL in...
Zebra Technologies Announces First-Quarter 2024 Results
First-Quarter Financial Highlights Net sales of $1,175 million; year-over-year decrease of 16.4% Net income of $115 million and net income...